BioLine RX Ltd Defensive Interval Ratio
BioLine RX Ltd defensive interval ratio. BioLine RX Ltd (BLRX) has a Defensive Interval Ratio of 245 days as of June 2026. Defensive assets of ILA9.12 Million (cash ILA-, short-term investments ILA8.39 Million, receivables ILA723.12K) cover 245 days of daily cash needs of ILA37.23K/day. Explore BLRX long-term investments to assets to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of BioLine RX Ltd (2005–2025)
Defensive interval ratio of BioLine RX Ltd from 2005 to 2025. This chart shows how BioLine RX Ltd's Defensive Interval Ratio has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 245 days, meaning defensive assets of ILA9.12 Million can fund 245 days of operations without new revenue. Read BioLine RX Ltd (BLRX) financial obligations for a breakdown of total debt and financial obligations.
BioLine RX Ltd Defensive Interval Ratio by Year (2005–2025)
BioLine RX Ltd defensive interval ratio by year from 2005 to 2025. The table below presents the year-by-year Defensive Interval Ratio for BioLine RX Ltd from 2005 to 2025, covering 21 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see BioLine RX Ltd balance sheet assets.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 544 days | ILA18.09 Million | ILA33.22K/day | ILA- | ILA17.63 Million | ▲ +237 days |
| 2024 | 308 days | ILA12.99 Million | ILA42.21K/day | ILA- | ILA9.13 Million | ▼ -29 days |
| 2023 | 337 days | ILA39.45 Million | ILA117.22K/day | ILA- | ILA38.74 Million | ▼ -1072 days |
| 2022 | 1409 days | ILA41.22 Million | ILA29.26K/day | ILA- | ILA40.49 Million | ▼ -254 days |
| 2021 | 1663 days | ILA44.29 Million | ILA26.63K/day | ILA- | ILA44.15 Million | ▲ +1461 days |
| 2020 | 202 days | ILA5.90 Million | ILA29.15K/day | ILA- | ILA5.76 Million | ▼ -493 days |
| 2019 | 696 days | ILA22.80 Million | ILA32.79K/day | ILA- | ILA22.19 Million | ▼ -823 days |
| 2018 | 1518 days | ILA28.09 Million | ILA18.50K/day | ILA- | ILA26.75 Million | ▼ -923 days |
| 2017 | 2441 days | ILA44.96 Million | ILA18.42K/day | ILA- | ILA44.37 Million | ▼ -886 days |
| 2016 | 3328 days | ILA33.38 Million | ILA10.03K/day | ILA- | ILA33.15 Million | ▼ -1602 days |
| 2015 | 4930 days | ILA42.41 Million | ILA8.60K/day | ILA- | ILA42.12 Million | ▲ +1175 days |
| 2014 | 3755 days | ILA29.85 Million | ILA7.95K/day | ILA- | ILA28.85 Million | ▲ +2472 days |
| 2013 | 1282 days | ILA10.54 Million | ILA8.22K/day | ILA- | ILA9.29 Million | ▲ +1074 days |
| 2012 | 208 days | ILA3.67 Million | ILA17.61K/day | ILA- | ILA3.07 Million | ▼ -780 days |
| 2011 | 988 days | ILA18.29 Million | ILA18.51K/day | ILA- | ILA17.28 Million | ▲ +510 days |
| 2010 | 478 days | ILA29.06 Million | ILA60.80K/day | ILA- | ILA28.04 Million | ▲ +123 days |
| 2009 | 355 days | ILA40.06 Million | ILA112.96K/day | ILA- | ILA- | ▼ -4 days |
| 2008 | 358 days | ILA36.64 Million | ILA102.27K/day | ILA- | ILA30.89 Million | ▲ +291 days |
| 2007 | 67 days | ILA4.53 Million | ILA67.44K/day | ILA- | ILA3.27 Million | ▼ -84 days |
| 2006 | 151 days | ILA3.43 Million | ILA22.72K/day | ILA- | ILA2.80 Million | ▲ +45 days |
| 2005 | 106 days | ILA1.33 Million | ILA12.50K/day | ILA- | ILA- | — |